Survivin is expressed in most common human cancers and although present during embryonic and foetal development, it is undetectable in a variety of adult tissues (Adida et al, 1998) and for this reason it is currently recognised as an important anticancer target (Fukuda and Pelus, 2006). This evidence concerns the gene BIRC5 and cancer.